Ono Pharmaceutical Co. Ltd.

OPHLY | OTC

Price Alert Chart Builder DCF Calculator

$5.33

+$0.18 (+3.50%)

Sep 22, 2026, 10:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q1 2027 Jun 29, 2026	Q4 2026 Mar 30, 2026	Q3 2026 Dec 30, 2025	Q2 2026 Sep 29, 2025	Q1 2026 Jun 29, 2025	Q4 2025 Mar 30, 2025	Q3 2025 Dec 30, 2024	Q2 2025 Sep 29, 2024	Q1 2025 Jun 29, 2024	Q4 2024 Mar 30, 2024	Q3 2024 Dec 30, 2023	Q2 2024 Sep 29, 2023	Q1 2024 Jun 29, 2023	Q4 2023 Mar 30, 2023	Q3 2023 Dec 30, 2022	Q2 2023 Sep 29, 2022	Q1 2023 Jun 29, 2022	Q4 2022 Mar 30, 2022	Q3 2022 Dec 30, 2021	Q2 2022 Sep 29, 2021	Q1 2022 Jun 29, 2021
Revenue	117.69B	120.93B	142.43B	131.86B	127.54B	112.31B	134.22B	122.66B	117.68B	112.77B	131.19B	138.7B	120.02B	108.17B	122.32B	109.98B	106.72B	89.93B	97.35B	86.71B	87.36B
Cost of Revenue	29.06B	33.67B	37.34B	35.57B	37.01B	45.24B	45.84B	27.21B	29.67B	31.66B	30.7B	34.59B	30.17B	26.28B	30.08B	26.78B	26.94B	22.88B	25.07B	22.77B	22.8B
Gross Profit	88.63B	87.26B	105.08B	96.29B	90.52B	67.07B	88.39B	95.46B	88B	81.11B	100.49B	104.1B	89.85B	81.89B	92.24B	83.2B	79.79B	67.05B	72.29B	63.95B	64.56B
Operating Income	31.59B	12.64B	38.64B	30.3B	22B	-11.01B	14.87B	25.55B	30.69B	15.31B	47.59B	55.69B	41.35B	19.37B	42.32B	42.11B	38.16B	21.03B	24B	28.38B	29.79B
Interest Income	1.4B	472.52M	1.41B	688.8M	655M	4.17M	2.53B	n/a	2.7B	787M	1.51B	1.24B	1.27B	69M	1.19B	65M	1.16B	173M	1.12B	105M	1.32B
Pretax Income	31.66B	3.34B	37.87B	30.04B	22.65B	-12.71B	17.4B	21.33B	33.31B	16.45B	48B	56.92B	42.38B	19.15B	43.36B	41.98B	39.04B	20.68B	25.12B	28.43B	30.8B
Net Income	24.47B	833.03M	29.38B	22.89B	17.67B	-6.55B	14.95B	16.85B	24.79B	17.43B	36.05B	42.67B	31.82B	17.07B	33.32B	32.86B	29.48B	15.9B	18.33B	22.22B	24.07B
Selling & General & Admin	24.21B	31.36B	32.3B	30.61B	31.09B	31.93B	35.32B	30.54B	27.89B	24.09B	25.69B	24.12B	23.48B	20.5B	23.2B	21.22B	21.73B	16.63B	19.83B	18.7B	18.96B
Research & Development	32.83B	43.27B	34.14B	35.38B	36.25B	42.79B	38.27B	39.95B	28.86B	35.68B	27.13B	24.78B	24.58B	29.37B	26.35B	20.22B	19.41B	26.42B	16.91B	17.31B	15.25B
Other Expenses	n/a	159.78	n/a	n/a	1.19B	3.35B	-70M	-571M	571M	2.88B	80M	-487M	435M	9.81B	376M	-339M	484M	41M	11.55B	-441M	572M
Operating Expenses	57.04B	74.63B	66.44B	65.99B	68.53B	78.08B	73.51B	69.91B	57.31B	62.66B	52.9B	48.42B	48.5B	62.52B	49.93B	41.1B	41.62B	46.03B	48.29B	35.57B	34.77B
Interest Expense	793.31M	1.15B	415.37M	1.25B	5.35M	1.82B	n/a	3.87B	75M	n/a	1.11B	20M	241M	289M	145M	199M	279M	521M	n/a	58M	303M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	30.65B	n/a	n/a	n/a	24.02B	n/a	n/a	n/a	17.84B	n/a	n/a	n/a	11.5B	n/a	n/a	n/a
Cost & Expenses	86.1B	108.29B	103.78B	101.56B	105.54B	123.32B	119.35B	97.12B	86.99B	94.32B	83.6B	83.01B	78.67B	88.79B	80B	67.87B	68.56B	68.9B	73.36B	58.34B	57.57B
Income Tax Expense	7.18B	2.28B	8.46B	7.3B	5.02B	-6.34B	2.51B	4.52B	8.47B	-988M	11.91B	14.22B	10.56B	2.07B	9.98B	9.06B	9.51B	4.66B	6.78B	6.2B	6.7B
Shares Outstanding (Basic)	1.41B	1.41B	1.41B	1.41B	1.41B	1.4B	1.41B	1.41B	1.41B	4.3B	4.28B	4.36B	4.4B	4.4B	4.4B	4.4B	4.39B	4.41B	4.48B	4.49B	4.49B
Shares Outstanding (Diluted)	1.41B	1.45B	1.41B	1.41B	1.41B	1.41B	1.41B	1.41B	1.41B	4.3B	4.28B	4.36B	4.4B	4.4B	4.4B	4.4B	4.4B	4.41B	4.48B	4.49B	4.49B
EPS (Basic)	17.76	0.59	20.85	16	12.54	-4.64	10.61	11.94	17.58	0.08	25.25	9.80	7.24	11.65	7.58	7.48	6.71	3.60	4.09	4.95	5.36
EPS (Diluted)	17.76	0.58	20.85	16	12.53	-4.66	10.60	11.94	17.58	12.50	25.25	9.80	7.24	11.64	7.58	7.48	6.71	3.60	4.09	4.94	5.36
EBITDA	40.69B	22.42B	48.06B	40.76B	31.23B	-5.79B	24.05B	29.81B	35.07B	20.38B	51.93B	61.49B	47.15B	23.94B	46.64B	46.43B	43.62B	25.83B	28.39B	32.78B	35.4B
EBIT	31.59B	12.64B	38.29B	31.29B	22B	-14.52B	14.88B	25.19B	30.69B	15.67B	49.1B	56.94B	42.62B	19.44B	43.51B	42.18B	39.32B	21.2B	24B	28.48B	31.11B
Depreciation & Amortization	9.1B	9.78B	9.77B	9.48B	9.24B	8.73B	9.17B	4.62B	4.38B	4.71B	4.34B	4.56B	4.53B	4.5B	4.32B	4.33B	4.3B	4.64B	4.4B	4.4B	4.29B